Mounjaro®
Starting from £179.99/mo
Start journey Learn moreUnderstanding the mg and ml figures on a Mounjaro KwikPen
Why is tirzepatide measured in mg when I can see liquid in the pen?
It is a common source of confusion, and an understandable one. Liquid medicines are often described by the volume you inject, insulin, for instance, is measured in units per ml, and people familiar with that system expect to calculate a volume. Tirzepatide works differently. The active ingredient, tirzepatide, is measured by mass (milligrams), because that is the biologically meaningful number: it tells you the amount of medicine interacting with your GLP-1 and GIP receptors. The liquid it is dissolved in is simply the carrier.
On a Mounjaro KwikPen, the injection volume is fixed at 0.5 ml per dose across every strength. What varies is how much tirzepatide is packed into that 0.5 ml. A 2.5 mg pen holds 10 mg of tirzepatide in 2 ml total (four doses of 0.5 ml, each delivering 2.5 mg). A 15 mg pen holds 60 mg in 2 ml total, so each 0.5 ml delivers 15 mg. The concentration (milligrams per millilitre) rises from 5 mg/ml to 30 mg/ml across the range, but the injection volume stays identical. The pen manages this for you; there is no dial, no syringe, and no ml figure you need to know to use it safely. The NHS tirzepatide patient information page confirms this fixed-volume design and is worth reading alongside your patient information leaflet.
The practical upshot: if someone quotes a tirzepatide "ml dose", treat that figure with caution. The dose that matters (clinically and legally) is always the mg figure your prescriber has specified.
What do the concentration figures look like across the full dose range?
The table below sets out the verified concentrations for each licensed Mounjaro strength. These figures come from the Mounjaro Summary of Product Characteristics published on the electronic Medicines Compendium (eMC) and are useful background, but they are not figures you need to act on.
| Pen strength | Total tirzepatide in pen | Total volume in pen | Concentration (mg/ml) | Volume per weekly dose |
|---|---|---|---|---|
| 2.5 mg | 10 mg | 2 ml | 5 mg/ml | 0.5 ml |
| 5 mg | 20 mg | 2 ml | 10 mg/ml | 0.5 ml |
| 7.5 mg | 30 mg | 2 ml | 15 mg/ml | 0.5 ml |
| 10 mg | 40 mg | 2 ml | 20 mg/ml | 0.5 ml |
| 12.5 mg | 50 mg | 2 ml | 25 mg/ml | 0.5 ml |
| 15 mg | 60 mg | 2 ml | 30 mg/ml | 0.5 ml |
The key point from this table is that the injection feel (the 0.5 ml of liquid entering the skin) is identical whether you are on the 2.5 mg starter dose or the 15 mg maintenance dose. Some people find this reassuring: moving up the dose ladder does not mean a larger injection. For a fuller explanation of how and why doses increase over time, the tirzepatide dosing guide covers the titration schedule in detail.
Does the ml volume matter for how I inject it?
For practical purposes, no. The KwikPen is a fixed-dose device. You do not draw up a volume, you do not estimate, and you do not convert mg to ml before pressing the button. The pen delivers 0.5 ml automatically, every time, at whichever concentration corresponds to the strength you have been prescribed.
What does matter is injection technique: choose a clean site on your abdomen, thigh or upper arm, rotate the site each week, and clean the skin beforehand. The needle goes on fresh for each injection. The Mounjaro SmPC on the electronic Medicines Compendium has step-by-step instructions, as does the patient information leaflet inside the box. Read both. Storage matters too, the pen sits in the fridge at 2–8 °C; for the exact room-temperature window if you need to travel, the patient information leaflet is the definitive source (the window varies by pen, and printing it in general content risks being out of date).
If you are currently on the 5 mg strength and wondering what comes next, or you are at 5 mg Mounjaro and thinking about dose timing, those questions belong in a clinical conversation rather than a concentration table. The ml figure in the pen does not change that conversation.
Could someone use these concentration figures to alter their dose at home?
This question deserves a direct answer: attempting to modify, split or otherwise interfere with a Mounjaro KwikPen is unsafe and defeats the purpose of the device entirely. The pen is engineered to deliver a precise, pre-set dose; any attempt to adjust volume would not reliably adjust the mg received and could introduce contamination, needle-stick risk or inaccurate dosing. None of that is a theoretical concern, it is the practical reality of a device designed for single-handed self-injection by people without clinical training.
If the dose you have been prescribed is not working well, or if side effects are troubling you, the right route is to speak to your prescriber. That is exactly what aftercare is for. At nume, every repeat order includes a fresh clinical review before dispatch, not because it is a regulatory tick-box, but because dose management is a clinical decision. The cost context for private treatment is summarised on our Mounjaro cost page if that is part of your thinking. When you are ready to take the next step, check your eligibility with our prescribers.
Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.